Cancer Screen

Targeted, low- to no-radiation cancer surveillance matched to your risk

PDF · 2 pages · 30 KB

In plain terms. This is a set of scans chosen based on your personal, family and genetic cancer risk, aiming to find cancers early — when treatment works best — while preferring tests that use little or no radiation. It is tailored: you receive the studies that fit your risk profile, not every scan.

What this screening includes

Whole-body diffusion MRI (DWI) — a radiation-free, head-to-thigh scan for multi-organ surveillance, especially for people with known genetic abnormalities or high-risk individuals.
Mammography & breast MRI — breast cancer screening; MRI adds sensitivity for women with dense breasts or those with an established high lifetime cancer risk.
Prostate MRI — evaluates the prostate without radiation and guides targeted biopsy when needed.
Low-dose chest CT — lung-cancer screening for people with a significant smoking or occupational exposure history.
CT colonography — a low-dose CT examination of the bowel for polyps and cancer.

What it is for & what it can find

Finding cancer earlier generally improves outcomes. Some of these tools also reduce over-treatment: MRI-guided prostate assessment may find early cancers that matter, whilst potentially sparing other men unnecessary biopsies, and low-dose CT led to reduced lung-cancer deaths by about 20% in eligible smokers in a large trial.

Guideline programmes anchor the schedule — for example, breast screening from age 40 and colorectal screening from age 45 for average-risk adults — while genetic or family risk can justify earlier or radiation-free options such as whole-body MRI.

Benefits

Early detection, when treatment is most effective.
Whole-body MRI, prostate MRI and breast MRI use no radiation.
Standardised, quality-controlled reporting (ONCO-RADS, PI-RADS, Lung-RADS, BI-RADS).
Matched to your actual risk rather than a one-size-fits-all panel.

Limitations & things to consider

Low-dose chest CT and CT colonography use small amounts of radiation.
Overdiagnosis — finding slow, harmless disease that may never have caused problems.
False positives are common and can lead to biopsies, further scans, cost and anxiety.
Whole-body MRI in average-risk people has limited outcome evidence and frequently finds incidental spots; no test detects every cancer, and screening supplements rather than replaces dedicated diagnostic imaging.

Who should consider it

Known genetic risk (e.g., BRCA, Lynch or Li-Fraumeni) or a strong family history of cancer.
Adults 50–80 with a significant smoking history (lung screening).
Average-risk adults reaching guideline screening ages (breast from 40; colorectal from 45).
People with high oxidative-stress or carcinogen-exposure profiles seeking a baseline.

References

Independently sourced and verified (September 2026). Links open the original publications.

National Lung Screening Trial Research Team. Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening. N Engl J Med. 2011;365(5):395–409. https://doi.org/10.1056/NEJMoa1102873
US Preventive Services Task Force. Screening for Lung Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(10):962–970. https://doi.org/10.1001/jama.2021.1117
US Preventive Services Task Force. Screening for Breast Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2024;331(22):1918–1930. https://pubmed.ncbi.nlm.nih.gov/38687503/
US Preventive Services Task Force. Screening for Colorectal Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2021;325(19):1965–1977. https://pubmed.ncbi.nlm.nih.gov/34003218/
Kasivisvanathan V, Rannikko AS, Borghi M, et al. MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis (PRECISION). N Engl J Med. 2018;378(19):1767–1777. https://doi.org/10.1056/NEJMoa1801993
Petralia G, Koh DM, Attariwala R, et al. Oncologically Relevant Findings Reporting and Data System (ONCO-RADS): Guidelines for Whole-Body MRI for Cancer Screening. Radiology. 2021;299(3):494–507. https://doi.org/10.1148/radiol.2021201740

This information sheet is for education and to help you choose appropriate screening. It is not a diagnosis or medical advice. Screening tests have benefits and harms; discuss your personal situation with your doctor. All studies are performed and interpreted by specialist or subspecialist radiologists (HPCSA-compliant; radiation kept As Low As Reasonably Achievable).